BioMarin Pharmaceutical Inc. buy Barclays PLC
Start price
28.10.25
/
50%
€46.90
Target price
28.10.26
€68.62
Performance (%)
-2.09%
Price
16.04.26
€45.92
Summary
This prediction is currently active. With a performance of -2.09%, the BUY prediction by Barclays_PLC is trending in the wrong direction. This prediction currently runs until 28.10.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| BioMarin Pharmaceutical Inc. | -4.572% | -4.572% |
| iShares Core DAX® | 0,44 % | 3,03 % |
| iShares Nasdaq 100 | 3,82 % | 4,07 % |
| iShares Nikkei 225® | 1,15 % | 6,90 % |
| iShares S&P 500 | 2,37 % | 2,68 % |
Comments by Barclays_PLC for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical (NASDAQ:BMRN) had its price target lowered by analysts at Barclays PLC from $86.00 to $80.00. They now have an "overweight" rating on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Barclays_PLC for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€47.65
28.01.26
28.01.26
€66.71
28.01.27
28.01.27
-3.63%
16.04.26
16.04.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€62.80
04.10.24
04.10.24
€78.35
04.10.25
04.10.25
-24.70%
05.10.25
05.10.25
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€79.46
06.08.24
06.08.24
€100.74
06.08.25
06.08.25
-34.76%
07.08.25
07.08.25